Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Moderna raises COVID shot sales guidance on Japan, US pacts

Por: The Boston Globe Business August 03, 2023

thumbnail

Moderna raised its COVID-19 vaccine sales outlook for the year, finalizing contracts with Japan and several American health care companies as the US government largely stops paying for the shots.Moderna now sees sales of $6 billion to $8 billion, according to a statement Thursday, up from a previous prediction of at least $5 billion and in line with the analysts’ average estimate of $6.9 billion. The Cambridge-based company is in talks with... + full article



Similar News

Moderna poised to seek flu shot approval after trial results

Portland Press Herald USA World September 13, 2023

thumbnailModerna said a reformulated version of its messenger-RNA-based flu shot met its primary goals in a final-stage trial – a result that could pave the way for the company to seek regulatory approval for the influenza vaccine. In a trial on over 2,400 adults, the reformulated shot... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


As demand for COVID shots wanes, biotech superstar Moderna seeks its next success

The Boston Globe USA Business June 23, 2023

thumbnailModerna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.Basking in the accolades heaped on Moderna’s celebrated COVID-19 vaccine, Afeyan regaled the Boston audience with the company’s... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

High school scores and top performers from Friday, March 24 | Orlando Sentinel


Moderna adding 2,000 new workers this year

Fox Business USA Business March 11, 2023

thumbnailCheck out what's clicking on FoxBusiness.com has revealed it will add to its workforce and its U.S. office footprint. In a put out Friday, Moderna said it will add about 2,000 new employees around the world.Moderna’s hiring efforts seemingly contrast with the reductions... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna’s Covid Boom Is Ending. Why the Outlook Isn’t All Grim. | MarketWatch


Moderna’s Covid Boom Is Ending. Why the Outlook Isn’t All Grim.

MarketWatch USA Business February 28, 2023

thumbnailThe earnings announcement was a sort of rubber-hits-the-road moment for Moderna (ticker: MRNA), as investors, who have been generally anticipating a drop in Covid-19 vaccine sales ever since the jab first was authorized late 2020, for the first time could fully reckon what it... + más

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?

Forbes USA Business November 29, 2022

thumbnailGetty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Moderna sues Pfizer over patents behind COVID-19 vaccine

The Advocate USA Crime October 10, 2022

thumbnailvaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times



About iurex | Privacy Policy | Disclaimer |